Ondansetron Hydrochloride
NDC 51655-813, Ondansetron Hydrochloride, tablet, film coated, from Northwind Health Company, LLC.
- Product NDC
- 51655-813
- Status
- Listed
- Labeler
- Northwind Health Company, LLC
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA078539
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51655-813 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- ONDANSETRON HYDROCHLORIDE8 mg/1
Pharmacologic classes
Serotonin 3 Receptor Antagonists [MoA]; Serotonin-3 Receptor Antagonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51655-813-54 | 51655081354 | 15 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-813-54) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/db99c77a-0b01-9da6-e053-2a95a90a5199
Use it
Look up 51655-813 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51655-813 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51655-813. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.